カテゴリ： QYResearch, その他産業, 世界

神経デジタル薬の世界市場2025年：ソフトウェア、デバイス

■ 英語タイトル：Global Neurology Digital Therapeutics Market Research Report 2025

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7512）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7512
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：93
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥417,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥626,400見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥835,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[神経デジタル薬の世界市場2025年：ソフトウェア、デバイス]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は神経デジタル薬のグローバル市場について調査・分析し、世界の神経デジタル薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（ソフトウェア、デバイス）、用途別セグメント分析（病院、クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Livongo Health、Noom、Omada Health、Pear Therapeutics、WellDoc、Proteus Digital Health、Propeller Health、Akili Interactive Labs、Mango Health、Better Therapeutics、Happify、Kaia Health、Click Therapeuticsなどが含まれています。神経デジタル薬のグローバル市場は、2024年にXXX米ドル、2031年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。貿易戦争とロシア・ウクライナ戦争の影響は、神経デジタル薬市場規模を算出する際に考慮しました。

・神経デジタル薬市場の概要
- 神経デジタル薬の種類別セグメント
- 世界の神経デジタル薬市場規模：タイプ別分析（ソフトウェア、デバイス）
- 神経デジタル薬の用途別セグメント
- 世界の神経デジタル薬市場規模：用途別分析（病院、クリニック、その他）
- 世界の神経デジタル薬市場規模予測（2020年-2031年）

・神経デジタル薬市場の成長トレンド
- 神経デジタル薬の地域別市場規模（2020年-2031年）
- 神経デジタル薬市場ダイナミクス
- 神経デジタル薬の業界動向
- 神経デジタル薬市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：ソフトウェア、デバイス
- 世界の神経デジタル薬のタイプ別市場規模（2020年-2025年）
- 世界の神経デジタル薬のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、クリニック、その他
- 世界の神経デジタル薬の用途別市場規模（2020年-2025年）
- 世界の神経デジタル薬の用途別市場規模（2024年-2029年）

・神経デジタル薬の地域別市場規模
- 北米の神経デジタル薬市場規模（2020年-2031年）
- 米国の神経デジタル薬市場規模（2020年-2031年）
- ヨーロッパの神経デジタル薬市場規模（2020年-2031年）
- アジア太平洋の神経デジタル薬市場規模（2020年-2031年）
- 中国の神経デジタル薬市場規模（2020年-2031年）
- 日本の神経デジタル薬市場規模（2020年-2031年）
- 韓国の神経デジタル薬市場規模（2020年-2031年）
- インドの神経デジタル薬市場規模（2020年-2031年）
- オーストラリアの神経デジタル薬市場規模（2020年-2031年）
- 中南米の神経デジタル薬市場規模（2020年-2031年）
- 中東・アフリカの神経デジタル薬市場規模（2020年-2031年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Livongo Health、Noom、Omada Health、Pear Therapeutics、WellDoc、Proteus Digital Health、Propeller Health、Akili Interactive Labs、Mango Health、Better Therapeutics、Happify、Kaia Health、Click Therapeutics

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Neurology Digital Therapeutics market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of % during the forecast period 2025-2031. The influence of trade war and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Neurology Digital Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Neurology Digital Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Neurology Digital Therapeutics in Hospital is estimated to increase from $ million in 2023 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The key global companies of Neurology Digital Therapeutics include Livongo Health, Noom, Omada Health, Pear Therapeutics, WellDoc, Proteus Digital Health, Propeller Health, Akili Interactive Labs and Mango Health, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Neurology Digital Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurology Digital Therapeutics.
The Neurology Digital Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neurology Digital Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurology Digital Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Livongo Health
Noom
Omada Health
Pear Therapeutics
WellDoc
Proteus Digital Health
Propeller Health
Akili Interactive Labs
Mango Health
Better Therapeutics
Happify
Kaia Health
Click Therapeutics
Segment by Type
Software
Devices
Segment by Application
Hospital
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neurology Digital Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurology Digital Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Software
1.2.3 Devices
1.3 Market by Application
1.3.1 Global Neurology Digital Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurology Digital Therapeutics Market Perspective (2020-2031)
2.2 Neurology Digital Therapeutics Growth Trends by Region
2.2.1 Global Neurology Digital Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Neurology Digital Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Neurology Digital Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Neurology Digital Therapeutics Market Dynamics
2.3.1 Neurology Digital Therapeutics Industry Trends
2.3.2 Neurology Digital Therapeutics Market Drivers
2.3.3 Neurology Digital Therapeutics Market Challenges
2.3.4 Neurology Digital Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurology Digital Therapeutics Players by Revenue
3.1.1 Global Top Neurology Digital Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Neurology Digital Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Neurology Digital Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neurology Digital Therapeutics Revenue
3.4 Global Neurology Digital Therapeutics Market Concentration Ratio
3.4.1 Global Neurology Digital Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurology Digital Therapeutics Revenue in 2022
3.5 Neurology Digital Therapeutics Key Players Head office and Area Served
3.6 Key Players Neurology Digital Therapeutics Product Solution and Service
3.7 Date of Enter into Neurology Digital Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurology Digital Therapeutics Breakdown Data by Type
4.1 Global Neurology Digital Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Neurology Digital Therapeutics Forecasted Market Size by Type (2026-2031)
5 Neurology Digital Therapeutics Breakdown Data by Application
5.1 Global Neurology Digital Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Neurology Digital Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Neurology Digital Therapeutics Market Size (2020-2031)
6.2 North America Neurology Digital Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Neurology Digital Therapeutics Market Size by Country (2020-2025)
6.4 North America Neurology Digital Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neurology Digital Therapeutics Market Size (2020-2031)
7.2 Europe Neurology Digital Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Neurology Digital Therapeutics Market Size by Country (2020-2025)
7.4 Europe Neurology Digital Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neurology Digital Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Neurology Digital Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Neurology Digital Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Neurology Digital Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neurology Digital Therapeutics Market Size (2020-2031)
9.2 Latin America Neurology Digital Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Neurology Digital Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Neurology Digital Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurology Digital Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Neurology Digital Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Neurology Digital Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Neurology Digital Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Livongo Health
11.1.1 Livongo Health Company Detail
11.1.2 Livongo Health Business Overview
11.1.3 Livongo Health Neurology Digital Therapeutics Introduction
11.1.4 Livongo Health Revenue in Neurology Digital Therapeutics Business (2020-2025)
11.1.5 Livongo Health Recent Development
11.2 Noom
11.2.1 Noom Company Detail
11.2.2 Noom Business Overview
11.2.3 Noom Neurology Digital Therapeutics Introduction
11.2.4 Noom Revenue in Neurology Digital Therapeutics Business (2020-2025)
11.2.5 Noom Recent Development
11.3 Omada Health
11.3.1 Omada Health Company Detail
11.3.2 Omada Health Business Overview
11.3.3 Omada Health Neurology Digital Therapeutics Introduction
11.3.4 Omada Health Revenue in Neurology Digital Therapeutics Business (2020-2025)
11.3.5 Omada Health Recent Development
11.4 Pear Therapeutics
11.4.1 Pear Therapeutics Company Detail
11.4.2 Pear Therapeutics Business Overview
11.4.3 Pear Therapeutics Neurology Digital Therapeutics Introduction
11.4.4 Pear Therapeutics Revenue in Neurology Digital Therapeutics Business (2020-2025)
11.4.5 Pear Therapeutics Recent Development
11.5 WellDoc
11.5.1 WellDoc Company Detail
11.5.2 WellDoc Business Overview
11.5.3 WellDoc Neurology Digital Therapeutics Introduction
11.5.4 WellDoc Revenue in Neurology Digital Therapeutics Business (2020-2025)
11.5.5 WellDoc Recent Development
11.6 Proteus Digital Health
11.6.1 Proteus Digital Health Company Detail
11.6.2 Proteus Digital Health Business Overview
11.6.3 Proteus Digital Health Neurology Digital Therapeutics Introduction
11.6.4 Proteus Digital Health Revenue in Neurology Digital Therapeutics Business (2020-2025)
11.6.5 Proteus Digital Health Recent Development
11.7 Propeller Health
11.7.1 Propeller Health Company Detail
11.7.2 Propeller Health Business Overview
11.7.3 Propeller Health Neurology Digital Therapeutics Introduction
11.7.4 Propeller Health Revenue in Neurology Digital Therapeutics Business (2020-2025)
11.7.5 Propeller Health Recent Development
11.8 Akili Interactive Labs
11.8.1 Akili Interactive Labs Company Detail
11.8.2 Akili Interactive Labs Business Overview
11.8.3 Akili Interactive Labs Neurology Digital Therapeutics Introduction
11.8.4 Akili Interactive Labs Revenue in Neurology Digital Therapeutics Business (2020-2025)
11.8.5 Akili Interactive Labs Recent Development
11.9 Mango Health
11.9.1 Mango Health Company Detail
11.9.2 Mango Health Business Overview
11.9.3 Mango Health Neurology Digital Therapeutics Introduction
11.9.4 Mango Health Revenue in Neurology Digital Therapeutics Business (2020-2025)
11.9.5 Mango Health Recent Development
11.10 Better Therapeutics
11.10.1 Better Therapeutics Company Detail
11.10.2 Better Therapeutics Business Overview
11.10.3 Better Therapeutics Neurology Digital Therapeutics Introduction
11.10.4 Better Therapeutics Revenue in Neurology Digital Therapeutics Business (2020-2025)
11.10.5 Better Therapeutics Recent Development
11.11 Happify
11.11.1 Happify Company Detail
11.11.2 Happify Business Overview
11.11.3 Happify Neurology Digital Therapeutics Introduction
11.11.4 Happify Revenue in Neurology Digital Therapeutics Business (2020-2025)
11.11.5 Happify Recent Development
11.12 Kaia Health
11.12.1 Kaia Health Company Detail
11.12.2 Kaia Health Business Overview
11.12.3 Kaia Health Neurology Digital Therapeutics Introduction
11.12.4 Kaia Health Revenue in Neurology Digital Therapeutics Business (2020-2025)
11.12.5 Kaia Health Recent Development
11.13 Click Therapeutics
11.13.1 Click Therapeutics Company Detail
11.13.2 Click Therapeutics Business Overview
11.13.3 Click Therapeutics Neurology Digital Therapeutics Introduction
11.13.4 Click Therapeutics Revenue in Neurology Digital Therapeutics Business (2020-2025)
11.13.5 Click Therapeutics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Neurology Digital Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Software
Table 3. Key Players of Devices
Table 4. Global Neurology Digital Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Neurology Digital Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Neurology Digital Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Neurology Digital Therapeutics Market Share by Region (2020-2025)
Table 8. Global Neurology Digital Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Neurology Digital Therapeutics Market Share by Region (2026-2031)
Table 10. Neurology Digital Therapeutics Market Trends
Table 11. Neurology Digital Therapeutics Market Drivers
Table 12. Neurology Digital Therapeutics Market Challenges
Table 13. Neurology Digital Therapeutics Market Restraints
Table 14. Global Neurology Digital Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Neurology Digital Therapeutics Market Share by Players (2020-2025)
Table 16. Global Top Neurology Digital Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurology Digital Therapeutics as of 2022)
Table 17. Ranking of Global Top Neurology Digital Therapeutics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Neurology Digital Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Neurology Digital Therapeutics Product Solution and Service
Table 21. Date of Enter into Neurology Digital Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neurology Digital Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Neurology Digital Therapeutics Revenue Market Share by Type (2020-2025)
Table 25. Global Neurology Digital Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Neurology Digital Therapeutics Revenue Market Share by Type (2026-2031)
Table 27. Global Neurology Digital Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Neurology Digital Therapeutics Revenue Market Share by Application (2020-2025)
Table 29. Global Neurology Digital Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Neurology Digital Therapeutics Revenue Market Share by Application (2026-2031)
Table 31. North America Neurology Digital Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Neurology Digital Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Neurology Digital Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Neurology Digital Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Neurology Digital Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Neurology Digital Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Neurology Digital Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Neurology Digital Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Neurology Digital Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Neurology Digital Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Neurology Digital Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Neurology Digital Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Neurology Digital Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Neurology Digital Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Neurology Digital Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Livongo Health Company Detail
Table 47. Livongo Health Business Overview
Table 48. Livongo Health Neurology Digital Therapeutics Product
Table 49. Livongo Health Revenue in Neurology Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 50. Livongo Health Recent Development
Table 51. Noom Company Detail
Table 52. Noom Business Overview
Table 53. Noom Neurology Digital Therapeutics Product
Table 54. Noom Revenue in Neurology Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 55. Noom Recent Development
Table 56. Omada Health Company Detail
Table 57. Omada Health Business Overview
Table 58. Omada Health Neurology Digital Therapeutics Product
Table 59. Omada Health Revenue in Neurology Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 60. Omada Health Recent Development
Table 61. Pear Therapeutics Company Detail
Table 62. Pear Therapeutics Business Overview
Table 63. Pear Therapeutics Neurology Digital Therapeutics Product
Table 64. Pear Therapeutics Revenue in Neurology Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 65. Pear Therapeutics Recent Development
Table 66. WellDoc Company Detail
Table 67. WellDoc Business Overview
Table 68. WellDoc Neurology Digital Therapeutics Product
Table 69. WellDoc Revenue in Neurology Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 70. WellDoc Recent Development
Table 71. Proteus Digital Health Company Detail
Table 72. Proteus Digital Health Business Overview
Table 73. Proteus Digital Health Neurology Digital Therapeutics Product
Table 74. Proteus Digital Health Revenue in Neurology Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 75. Proteus Digital Health Recent Development
Table 76. Propeller Health Company Detail
Table 77. Propeller Health Business Overview
Table 78. Propeller Health Neurology Digital Therapeutics Product
Table 79. Propeller Health Revenue in Neurology Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 80. Propeller Health Recent Development
Table 81. Akili Interactive Labs Company Detail
Table 82. Akili Interactive Labs Business Overview
Table 83. Akili Interactive Labs Neurology Digital Therapeutics Product
Table 84. Akili Interactive Labs Revenue in Neurology Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 85. Akili Interactive Labs Recent Development
Table 86. Mango Health Company Detail
Table 87. Mango Health Business Overview
Table 88. Mango Health Neurology Digital Therapeutics Product
Table 89. Mango Health Revenue in Neurology Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 90. Mango Health Recent Development
Table 91. Better Therapeutics Company Detail
Table 92. Better Therapeutics Business Overview
Table 93. Better Therapeutics Neurology Digital Therapeutics Product
Table 94. Better Therapeutics Revenue in Neurology Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 95. Better Therapeutics Recent Development
Table 96. Happify Company Detail
Table 97. Happify Business Overview
Table 98. Happify Neurology Digital Therapeutics Product
Table 99. Happify Revenue in Neurology Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 100. Happify Recent Development
Table 101. Kaia Health Company Detail
Table 102. Kaia Health Business Overview
Table 103. Kaia Health Neurology Digital Therapeutics Product
Table 104. Kaia Health Revenue in Neurology Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 105. Kaia Health Recent Development
Table 106. Click Therapeutics Company Detail
Table 107. Click Therapeutics Business Overview
Table 108. Click Therapeutics Neurology Digital Therapeutics Product
Table 109. Click Therapeutics Revenue in Neurology Digital Therapeutics Business (2020-2025) & (US$ Million)
Table 110. Click Therapeutics Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neurology Digital Therapeutics Market Size Comparison by Type (2025-2031) & (US$ Million)
Figure 2. Global Neurology Digital Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. Software Features
Figure 4. Devices Features
Figure 5. Global Neurology Digital Therapeutics Market Size Comparison by Application (2025-2031) & (US$ Million)
Figure 6. Global Neurology Digital Therapeutics Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Neurology Digital Therapeutics Report Years Considered
Figure 11. Global Neurology Digital Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Neurology Digital Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Neurology Digital Therapeutics Market Share by Region: 2022 VS 2029
Figure 14. Global Neurology Digital Therapeutics Market Share by Players in 2024
Figure 15. Global Top Neurology Digital Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurology Digital Therapeutics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Neurology Digital Therapeutics Revenue in 2024
Figure 17. North America Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Neurology Digital Therapeutics Market Share by Country (2020-2031)
Figure 19. United States Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Neurology Digital Therapeutics Market Share by Country (2020-2031)
Figure 23. Germany Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Neurology Digital Therapeutics Market Share by Region (2020-2031)
Figure 31. China Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Neurology Digital Therapeutics Market Share by Country (2020-2031)
Figure 39. Mexico Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Neurology Digital Therapeutics Market Share by Country (2020-2031)
Figure 43. Turkey Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Neurology Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Livongo Health Revenue Growth Rate in Neurology Digital Therapeutics Business (2020-2025)
Figure 46. Noom Revenue Growth Rate in Neurology Digital Therapeutics Business (2020-2025)
Figure 47. Omada Health Revenue Growth Rate in Neurology Digital Therapeutics Business (2020-2025)
Figure 48. Pear Therapeutics Revenue Growth Rate in Neurology Digital Therapeutics Business (2020-2025)
Figure 49. WellDoc Revenue Growth Rate in Neurology Digital Therapeutics Business (2020-2025)
Figure 50. Proteus Digital Health Revenue Growth Rate in Neurology Digital Therapeutics Business (2020-2025)
Figure 51. Propeller Health Revenue Growth Rate in Neurology Digital Therapeutics Business (2020-2025)
Figure 52. Akili Interactive Labs Revenue Growth Rate in Neurology Digital Therapeutics Business (2020-2025)
Figure 53. Mango Health Revenue Growth Rate in Neurology Digital Therapeutics Business (2020-2025)
Figure 54. Better Therapeutics Revenue Growth Rate in Neurology Digital Therapeutics Business (2020-2025)
Figure 55. Happify Revenue Growth Rate in Neurology Digital Therapeutics Business (2020-2025)
Figure 56. Kaia Health Revenue Growth Rate in Neurology Digital Therapeutics Business (2020-2025)
Figure 57. Click Therapeutics Revenue Growth Rate in Neurology Digital Therapeutics Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

※参考情報

神経デジタル薬は、神経系に関連する疾患や障害に対処するために設計されたデジタル治療法の一形式です。従来の薬物療法や治療法と異なり、スマートフォンアプリやウェブベースのプラットフォーム、バーチャルリアリティなどのデジタル技術を活用して、患者の症状を改善したり健康を促進したりすることを目的としています。この概念は、神経学の分野における新しい治療手段として注目を集めており、その効果や利便性から期待されるものです。

神経デジタル薬の特徴として、一つには、個々の患者のニーズに応じたパーソナライズされた治療に焦点を当てている点が挙げられます。デジタルプラットフォームは、ユーザーのデータ（フィードバックや生活習慣、症状の変化など）をリアルタイムで収集・分析し、その結果を基に適切な介入を提供します。そのため、個々の患者に合った治療法を展開することが可能となります。これにより、従来の一律な治療法から、より効果的で適切なケアへとシフトすることが期待されます。

もう一つの重要な特徴は、アクセスのしやすさです。多くの神経デジタル薬は、スマートフォンやタブレットにインストール可能なアプリとして提供されており、患者は医療機関を訪れずに自宅で治療を受けられます。これにより、地理的な制約や医療へのアクセスの困難さを軽減し、より広範な患者層に対して効果的な治療を提供することが可能です。

種類としては、神経デジタル薬は多岐にわたります。主に以下のような疾患や条件に対して開発されています。例えば、うつ病や不安障害、ADHD（注意欠陥多動性障害）、統合失調症、アルツハイマー病など、さまざまな神経精神的な疾患に特化したデジタルプログラムがあります。これらのプログラムは、認知行動療法（CBT）、マインドフルネス、バイオフィードバック、ゲームを取り入れた訓練など、さまざまなアプローチを基に設計されています。

用途としては、神経デジタル薬は主に症状の緩和や改善、患者の自己管理能力の向上、再発防止を目指しています。例えば、うつ病の患者に対しては、認知行動療法に基づくアプローチを用いて、思考パターンの修正を促すことができます。また、不安障害に対しては、リラクセーション技法やストレス管理の訓練を提供することにより、自分自身をコントロールする能力を高める手助けをします。

関連技術として、人工知能（AI）や機械学習の進展は、神経デジタル薬の発展に大きく寄与しています。これらの技術は、患者の行動や症状のパターンを解析し、個別の治療法を推奨することを可能にします。また、データの分析によって治療効果の評価や改善点の特定が行えるため、治療法の効果を科学的に裏付けることにつながります。

さらに、バイオフィードバックやウェアラブルデバイスの使用も、神経デジタル薬の進化を促進しています。これらのデバイスは、心拍数や脳波、睡眠パターンなどの生理的データをリアルタイムで測定し、ユーザーに提供することで、ストレス管理や睡眠改善に役立ちます。データを可視化することにより、ユーザーは自分の状態をより良く理解し、自己管理に活用することができるようになります。

最後に、神経デジタル薬は従来の治療法と併用されることが多く、それによって相乗効果を生むことが期待されています。例えば、薬物治療を受けている患者が神経デジタル薬を併用することで、症状の改善がより促進される可能性があります。そのため、医療従事者による指導のもとでの併用が推奨されることが多いです。

総じて、神経デジタル薬は革新的な治療アプローチとして、多くの患者に新たな可能性を提供しています。デジタル技術を活用した個別化されたケアは、従来の医療体系に便利さと効率をもたらす可能性があり、今後の神経学の発展において重要な役割を果たすと考えられます。患者のニーズに応じた柔軟な治療法として、今後ますます普及していくことが期待されます。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • デジタル治療薬のグローバル市場2023-2027：ソフトウェア、デバイス
  • デジタル病理のグローバル市場（2024～2030）：ソフトウェア、デバイス、ストレージシステム
  • 世界の気道陽圧デバイス市場予測（2024年-2032年）：製品種類別（自動気道陽圧（APAP）デバイス、持続気道陽圧（CPAP）デバイス、バイレベル気道陽圧（BiPAP）デバイス）、エンドユーザー別（病院・睡眠研究所、在宅ケア、その他）、地域別
  • ピペット校正器の世界市場（2023年～2030年）：デバイス、ソフトウェア
  • ガラス化の世界市場2025-2031：卵子（デバイス、キット、消耗品）、胚（デバイス、キット、消耗品）、精子
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7512 )"神経デジタル薬の世界市場2025年：ソフトウェア、デバイス" (英文：Global Neurology Digital Therapeutics Market Research Report 2025)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。